2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide

C21H23BrF2N4O4S — CID 58509075

IUPAC2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide
SMILESN#Cc1cccn1CCC(NS(=O)(=O)c1c(F)cc(F)cc1Br)C(=O)N1CCC(CO)CC1
InChIInChI=1S/C21H23BrF2N4O4S/c22-17-10-15(23)11-18(24)20(17)33(31,32)26-19(5-9-27-6-1-2-16(27)12-25)21(30)28-7-3-14(13-29)4-8-28/h1-2,6,10-11,14,19,26,29H,3-5,7-9,13H2
InChIKeyANCLFURQUSMAJX-UHFFFAOYSA-N
MW545.41 g/mol
LogP2.37
Rot. Bonds8

About 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide

2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide (PubChem CID 58509075) has the molecular formula C21H23BrF2N4O4S and a molecular weight of 545.41 g/mol. Its IUPAC name is 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide.

Molecular Properties

Compound Name2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide
PubChem CID58509075
Molecular FormulaC21H23BrF2N4O4S
Molecular Weight545.41 g/mol
Exact Mass544.06
IUPAC Name2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide
SMILESN#Cc1cccn1CCC(NS(=O)(=O)c1c(F)cc(F)cc1Br)C(=O)N1CCC(CO)CC1
InChIInChI=1S/C21H23BrF2N4O4S/c22-17-10-15(23)11-18(24)20(17)33(31,32)26-19(5-9-27-6-1-2-16(27)12-25)21(30)28-7-3-14(13-29)4-8-28/h1-2,6,10-11,14,19,26,29H,3-5,7-9,13H2
InChIKeyANCLFURQUSMAJX-UHFFFAOYSA-N
XLogP2.37
TPSA115.43 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500545.41
LogP ≤ 52.37
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide?
The IUPAC name of 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide (CID 58509075) is 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide.
What is the SMILES notation for 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide?
The canonical SMILES for 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide is N#Cc1cccn1CCC(NS(=O)(=O)c1c(F)cc(F)cc1Br)C(=O)N1CCC(CO)CC1.
What is the InChIKey of 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide?
The InChIKey is ANCLFURQUSMAJX-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H23BrF2N4O4S/c22-17-10-15(23)11-18(24)20(17)33(31,32)26-19(5-9-27-6-1-2-16(27)12-25)21(30)28-7-3-14(13-29)4-8-28/h1-2,6,10-11,14,19,26,29H,3-5,7-9,13H2.
What are the key properties of 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide?
2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide has a molecular weight of 545.41 g/mol, XLogP of 2.37, 8 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-bromo-N-[4-(2-cyanopyrrol-1-yl)-1-[4-(hydroxymethyl)piperidin-1-yl]-1-oxobutan-2-yl]-4,6-difluorobenzenesulfonamide is sourced from PubChem (CID 58509075), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).